Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of pemetrexed plus cisplatin in patients with refractory soft tissue sarcoma
KCT0003542Phase 2Recruiting
- Sponsor
- Boryung
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, cisplatin in soft tissue sarcoma (STS), sponsored by Boryung. Started Jan 2017; status: recruiting.
02
Drugs
pemetrexedcisplatin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on KCT0003542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003542.